Fil LTD Autolus Therapeutics PLC Transaction History

Fil LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$24.21 - $48.01 $3.8 Million - $7.53 Million	-156,916 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$20.86 - $33.33 $5.75 Million - $9.19 Million	-275,758 Reduced 63.73%	156,916 $4.73 Million
Q2 2018 Aug 10, 2018	BUY	$25.0 - $27.75 $10.8 Million - $12 Million	432,674 New	432,674 $11.6 Million

103

150M

24.6K

41.9K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $126M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.